HOLUBOVA, Adela, Lucie CHLUPACOVA, Jitka KROCOVA, Lada CETLOVA, Linsey J F PETERS, Niels A J CREMERS and Andrea POKORNÁ. The Use of Medical Grade Honey on Infected Chronic Diabetic Foot Ulcers-A Prospective Case-Control Study. Antibiotics-Basel. BASEL: MDPI, 2023, vol. 12, No 9, p. 1-18. ISSN 2079-6382. Available from: https://dx.doi.org/10.3390/antibiotics12091364.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name The Use of Medical Grade Honey on Infected Chronic Diabetic Foot Ulcers-A Prospective Case-Control Study
Authors HOLUBOVA, Adela (203 Czech Republic), Lucie CHLUPACOVA (203 Czech Republic), Jitka KROCOVA (203 Czech Republic), Lada CETLOVA (203 Czech Republic), Linsey J F PETERS (528 Netherlands), Niels A J CREMERS (528 Netherlands) and Andrea POKORNÁ (203 Czech Republic, belonging to the institution).
Edition Antibiotics-Basel, BASEL, MDPI, 2023, 2079-6382.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30307 Nursing
Country of publisher Switzerland
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 4.800 in 2022
RIV identification code RIV/00216224:14110/23:00132218
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.3390/antibiotics12091364
UT WoS 001071367300001
Keywords in English medical grade honey; diabetic foot ulcer; diabetes; anti-inflammatory treatment; glycaemia
Tags 14110611, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 13/11/2023 08:58.
Abstract
Non-healing wounds are usually colonised and contaminated by different types of bacteria. An alternative to antibiotic treatment in patients with infected wounds with local signs of inflammation may be medical grade honey (MGH). MGH has antioxidant, antimicrobial, anti-inflammatory, and immunomodulatory features. This study aims to evaluate the effect of MGH therapy on infected non-healing wounds, especially for diabetic foot syndrome. Prospective, observational case series (n = 5) of patients with wounds of diabetic foot syndrome are presented. There were five males with an average age of 61.6 years. All wounds were treated with MGH, and the healing trajectory was rigorously and objectively monitored. In all cases, there was a gradual disappearance of odour, pain, and exudation. Moreover, the wound areas significantly reduced within 40 days and there was a decrease in glycated haemoglobin and glycaemia values. All these outcomes resulted in improved quality of life of the patients. Despite bacterial colonisation, antibiotic treatment was not necessary. All wounds were completely healed. MGH has antimicrobial, anti-inflammatory, and antioxidant effects in diabetic foot syndrome wounds, does not increase glycated haemoglobin or glycaemia levels, and thus constitutes an effective alternative to the use of antibiotics in the treatment of locally infected wounds.
PrintDisplayed: 11/7/2024 19:42